Endo to Acquire Qualitest Pharmaceuticals in Move to Build Up Generics

Drug Industry Daily
A A
Endo Pharmaceuticals has moved to strengthen its generic drug business, agreeing to acquire Qualitest Pharmaceuticals for $1.2 billion.

To View This Article:

Login

Subscribe To Drug Industry Daily